124 related articles for article (PubMed ID: 33752091)
1. Reconstruction and analysis of correlation networks based on GC-MS metabolomics data for hypercholesterolemia.
OuYang YN; Zhou LX; Jin YX; Hou GF; Yang PF; Chen M; Tian Z
Biochem Biophys Res Commun; 2021 May; 553():1-8. PubMed ID: 33752091
[TBL] [Abstract][Full Text] [Related]
2. Metabolic profiling of potential lung cancer biomarkers using bronchoalveolar lavage fluid and the integrated direct infusion/ gas chromatography mass spectrometry platform.
Callejón-Leblic B; García-Barrera T; Grávalos-Guzmán J; Pereira-Vega A; Gómez-Ariza JL
J Proteomics; 2016 Aug; 145():197-206. PubMed ID: 27255828
[TBL] [Abstract][Full Text] [Related]
3. Reconstruction and analysis of correlation networks based on GC-MS metabolomics data for young hypertensive men.
Wang L; Hou E; Wang L; Wang Y; Yang L; Zheng X; Xie G; Sun Q; Liang M; Tian Z
Anal Chim Acta; 2015 Jan; 854():95-105. PubMed ID: 25479872
[TBL] [Abstract][Full Text] [Related]
4. Apolipoprotein(a) phenotype determines the correlations of lipoprotein(a) and proprotein convertase subtilisin/kexin type 9 levels in patients with potential familial hypercholesterolemia.
Afanasieva OI; Ezhov MV; Razova OA; Afanasieva MI; Utkina EA; Pokrovsky SN
Atherosclerosis; 2018 Oct; 277():477-482. PubMed ID: 30270088
[TBL] [Abstract][Full Text] [Related]
5. Metabolic changes in paraquat poisoned patients and support vector machine model of discrimination.
Wang X; Zhang M; Ma J; Zhang Y; Hong G; Sun F; Lin G; Hu L
Biol Pharm Bull; 2015; 38(3):470-5. PubMed ID: 25757930
[TBL] [Abstract][Full Text] [Related]
6. Serum proprotein convertase subtilisin/kexin type 9 concentration is not increased by plant stanol ester consumption in normo- to moderately hypercholesterolaemic non-obese subjects. The BLOOD FLOW intervention study.
Simonen P; Stenman UH; Gylling H
Clin Sci (Lond); 2015 Sep; 129(5):439-46. PubMed ID: 25857271
[TBL] [Abstract][Full Text] [Related]
7. Serum amino acid metabolic profiles of ankylosing spondylitis by targeted metabolomics analysis.
Zhou Y; Zhang X; Chen R; Han S; Liu Y; Liu X; Gao M; Yang C; Lu D; Sun B; Chen H
Clin Rheumatol; 2020 Aug; 39(8):2325-2336. PubMed ID: 32130577
[TBL] [Abstract][Full Text] [Related]
8. [Detection and analysis on plasma metabolomics in patient with coronary heart disease of Xin-blood stasis syndrome pattern].
Jian WX; Yuan ZK; Huang XP
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2010 Jun; 30(6):579-84. PubMed ID: 20815270
[TBL] [Abstract][Full Text] [Related]
9. Effect of arginine:lysine and glycine:methionine intake ratios on dyslipidemia and selected biomarkers implicated in cardiovascular disease: A study with hypercholesterolemic rats.
Venkatesh R; Srinivasan K; Singh SA
Biomed Pharmacother; 2017 Jul; 91():408-414. PubMed ID: 28475919
[TBL] [Abstract][Full Text] [Related]
10. Lipid metabolic dysregulation is involved in Parkinson's disease dementia.
Dong MX; Wei YD; Hu L
Metab Brain Dis; 2021 Mar; 36(3):463-470. PubMed ID: 33433787
[TBL] [Abstract][Full Text] [Related]
11. AMG145, a monoclonal antibody against proprotein convertase subtilisin kexin type 9, significantly reduces lipoprotein(a) in hypercholesterolemic patients receiving statin therapy: an analysis from the LDL-C Assessment with Proprotein Convertase Subtilisin Kexin Type 9 Monoclonal Antibody Inhibition Combined with Statin Therapy (LAPLACE)-Thrombolysis in Myocardial Infarction (TIMI) 57 trial.
Desai NR; Kohli P; Giugliano RP; O'Donoghue ML; Somaratne R; Zhou J; Hoffman EB; Huang F; Rogers WJ; Wasserman SM; Scott R; Sabatine MS
Circulation; 2013 Aug; 128(9):962-9. PubMed ID: 23884353
[TBL] [Abstract][Full Text] [Related]
12. Mutations and polymorphisms in the proprotein convertase subtilisin kexin 9 (PCSK9) gene in cholesterol metabolism and disease.
Abifadel M; Rabès JP; Devillers M; Munnich A; Erlich D; Junien C; Varret M; Boileau C
Hum Mutat; 2009 Apr; 30(4):520-9. PubMed ID: 19191301
[TBL] [Abstract][Full Text] [Related]
13. [Preliminary exploration of the metabolic profile and metabolic pathways in newly diagnosed multiple myeloma].
Huang QL; Zhao RR; Yang BY; Jiang RY; Yang LL; Yan S; Fu ZZ; Wu DP; Wu XJ
Zhonghua Zhong Liu Za Zhi; 2022 Dec; 44(12):1369-1375. PubMed ID: 36575789
[No Abstract] [Full Text] [Related]
14. GC-MS-Based metabolomics discovers a shared serum metabolic characteristic among three types of epileptic seizures.
Wang D; Wang X; Kong J; Wu J; Lai M
Epilepsy Res; 2016 Oct; 126():83-9. PubMed ID: 27450370
[TBL] [Abstract][Full Text] [Related]
15. Proprotein Convertase Subtilisin Kexin Type 9 Inhibition for Autosomal Recessive Hypercholesterolemia-Brief Report.
Thedrez A; Sjouke B; Passard M; Prampart-Fauvet S; Guédon A; Croyal M; Dallinga-Thie G; Peter J; Blom D; Ciccarese M; Cefalù AB; Pisciotta L; Santos RD; Averna M; Raal F; Pintus P; Cossu M; Hovingh K; Lambert G
Arterioscler Thromb Vasc Biol; 2016 Aug; 36(8):1647-50. PubMed ID: 27079874
[TBL] [Abstract][Full Text] [Related]
16. Plasma inducible degrader of the LDLR, soluble low-density lipoprotein receptor, and proprotein convertase subtilisin/kexin type 9 levels as potential biomarkers of familial hypercholesterolemia in children.
Girona J; Rodríguez-Borjabad C; Ibarretxe D; Heras M; Amigo N; Feliu A; Masana L; Plana N;
J Clin Lipidol; 2018; 12(1):211-218. PubMed ID: 29102496
[TBL] [Abstract][Full Text] [Related]
17. LC-MS-based serum metabolomics reveals a distinctive signature in patients with rheumatoid arthritis.
Li J; Che N; Xu L; Zhang Q; Wang Q; Tan W; Zhang M
Clin Rheumatol; 2018 Jun; 37(6):1493-1502. PubMed ID: 29442259
[TBL] [Abstract][Full Text] [Related]
18. Serum metabolomics reveals the progression of coronary artery stenosis in patients with hypercholesterolemia: a pilot study.
Qiu Q; Wang Y; Jing S; Chen Y; Cao J; Pan Y; Ye M; Lin Y
Blood Coagul Fibrinolysis; 2019 Jul; 30(5):205-216. PubMed ID: 31157678
[TBL] [Abstract][Full Text] [Related]
19. Influence of PCSK9 polymorphisms on plasma lipids and response to atorvastatin treatment in Brazilian subjects.
Anderson JM; Cerda A; Hirata MH; Rodrigues AC; Dorea EL; Bernik MM; Bertolami MC; Faludi AA; Hirata RD
J Clin Lipidol; 2014; 8(3):256-64. PubMed ID: 24793346
[TBL] [Abstract][Full Text] [Related]
20. Revealing metabolic pathways relevant to prediabetes based on metabolomics profiling analysis.
OuYang YN; Jin YX; Zhao XR; Chen M; Yang PF; Zheng XW; Zeng L; Chen L; Tian Z
Biochem Biophys Res Commun; 2020 Nov; 533(1):188-194. PubMed ID: 32958245
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
